| Product Code: ETC9495516 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Neurology Clinical Trials Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Neurology Clinical Trials Market - Industry Life Cycle |
3.4 Sudan Neurology Clinical Trials Market - Porter's Five Forces |
3.5 Sudan Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Sudan Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 Sudan Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Sudan Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Sudan |
4.2.2 Growing awareness about clinical trials and their benefits in neurology |
4.2.3 Government initiatives to support and promote research in neurology |
4.3 Market Restraints |
4.3.1 Limited funding and resources for conducting clinical trials |
4.3.2 Lack of skilled healthcare professionals specialized in neurology |
4.3.3 Regulatory challenges and bureaucracy in the approval process for clinical trials |
5 Sudan Neurology Clinical Trials Market Trends |
6 Sudan Neurology Clinical Trials Market, By Types |
6.1 Sudan Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Sudan Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Sudan Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 Sudan Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 Sudan Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 Sudan Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Sudan Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 Sudan Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Sudan Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 Sudan Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 Sudan Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Sudan Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 Sudan Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Sudan Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 Sudan Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 Sudan Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Sudan Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 Sudan Neurology Clinical Trials Market Export to Major Countries |
7.2 Sudan Neurology Clinical Trials Market Imports from Major Countries |
8 Sudan Neurology Clinical Trials Market Key Performance Indicators |
8.1 Number of new neurological clinical trials initiated annually |
8.2 Percentage of successful completion of neurology clinical trials |
8.3 Patient recruitment and retention rates in neurology clinical trials |
8.4 Average time taken for regulatory approval of neurology clinical trials |
8.5 Number of publications and presentations resulting from neurology clinical trials |
9 Sudan Neurology Clinical Trials Market - Opportunity Assessment |
9.1 Sudan Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Sudan Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 Sudan Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Sudan Neurology Clinical Trials Market - Competitive Landscape |
10.1 Sudan Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Sudan Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here